Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,901
Closed -$145K 115
2026
Q1
$145K Buy
+21,901
New +$141K 1.47% 12
2025
Q4
Sell
-20,905
Closed -$131K 948
2025
Q3
$131K Buy
+20,905
New +$129K 0.07% 591
2025
Q1
Sell
-104,974
Closed -$732K 474
2024
Q4
$732K Buy
+104,974
New +$711K 0.62% 13

Other funds holding QUAD

PharVision Advisers's QUAD Position: Q2 2026 in Review

PharVision Advisers sold out of Quad (QUAD) in Q2 2026, closing a stake of 21,901 shares — an estimated $145K sold.

PharVision Advisers first reported a position in QUAD in Q4 2024 and held it in 3 quarters. The position peaked at $732K in Q4 2024. 145 funds tracked by Wall St. Rank hold QUAD as of Q2 2026.

  • PharVision Advisers reported no remaining Quad position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 21,901 Quad shares in Q2 2026, an estimated $145K.
  • PharVision Advisers first reported a position in Quad in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Quad position peaked at $732K in Q4 2024.
  • 145 funds tracked by Wall St. Rank held Quad as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.